-transparent.png){kind=logo}
Analysing preliminary results of percutaneous radiotherapy on 79 patients with localized prostatic carcinoma, the uncorrected five-year survival rate of all patients was 67.3%, that in stage O, A and B 89.5% and that of patients in stage C and D 64.5%. The tumour-free five-year survival rate of all patients was 50.2%. In three patients there was a recurrence (4%), in four others severe side-effects (5%). There were no fatal complications. Radiotherapy can be considered to be an alternative to operation even when the tumour is limited to the prostate.
Related Publications
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
December 1997,
Harefuah,
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
December 1979,
Revue francaise des maladies respiratoires,
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
June 1977,
Der Radiologe,
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
November 1979,
La Nouvelle presse medicale,
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
October 1976,
Deutsche medizinische Wochenschrift (1946),
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
May 1981,
La Radiologia medica,
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
February 1974,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
November 1978,
Der Urologe. Ausg. A,
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
March 1981,
Strahlentherapie,
G Schmitt, and
W Lenz, and
P Mellin, and
E Scherer, and
K Schulte-Vels
January 1980,
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
